{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:34:04Z","timestamp":1780990444001,"version":"3.54.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The prognostic impact of thrombocytopenia in patients supported by extracorporeal membrane oxygenation after cardiac surgery is uncertain. We investigated whether thrombocytopenia is independently predictive of poor outcome and describe the incidence and time course of thrombocytopenia in extracorporeal membrane oxygenation patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective analysis of prospectively collected data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Cardiosurgical ICU at a tertiary referral center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Three hundred adult patients supported with venoarterial extracorporeal membrane oxygenation for more than 24 hours because of refractory cardiogenic shock after heart surgery between January 2001 and December 2014.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Two-way analysis of variance was used to compare the time course of platelet count changes between survivors and nonsurvivors. Using multiple Cox regression with time-dependent covariates, we investigated the impact of platelet count on 90-day mortality. In nonsurvivors, the daily incidence of moderate (&lt; 100 \u2013 50\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L), severe (49 \u2013 20\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L), and very severe (&lt; 20\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) thrombocytopenia was 50%, 54%, and 7%, respectively. Platelet count had a biphasic temporal pattern with an initial decrease until day 4\u20135 after the initiation of extracorporeal membrane oxygenation. Although a significant recovery of the platelet count was observed in survivors, a recovery did not occur in nonsurvivors (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0001). After adjusting for suspected confounders, moderate, severe, and very severe thrombocytopenia were independently associated with 90-day mortality. The highest risk was associated with severe (hazard ratio, 5.9 [2.7\u201312.6]; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001) and very severe thrombocytopenia (hazard ratio, 25.9 [10.7\u201362.9], <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.0001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Thrombocytopenia is an independent risk factor for poor outcome in extracorporeal membrane oxygenation patients after cardiac surgery, with persistent severe thrombocytopenia likely reflecting a high degree of physiologic imbalance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000001964","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T16:38:05Z","timestamp":1470760685000},"page":"e1208-e1218","source":"Crossref","is-referenced-by-count":40,"title":["Prognostic Impact of Persistent Thrombocytopenia During Extracorporeal Membrane Oxygenation: A Retrospective Analysis of Prospectively Collected Data From a Cohort of Patients With Left Ventricular Dysfunction After Cardiac Surgery"],"prefix":"10.1097","volume":"44","author":[{"given":"Philipp","family":"Opfermann","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bevilacqua","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Felli","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mouhieddine","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodor","family":"Bachleda","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Pichler","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hiesmayr","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Zuckermann","sequence":"additional","affiliation":[{"name":"Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dworschak","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Steinlechner","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic and Vascular Anesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1525-1594.2007.00388.x","article-title":"Argatroban in extracorporeal membrane oxygenation.","volume":"31","author":"Beiderlinden","year":"2007","journal-title":"Artif Organs"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1213\/ANE.0000000000000115","article-title":"Extracorporeal membrane oxygenation in the adult: A review of anticoagulation monitoring and transfusion.","volume":"118","author":"Esper","year":"2014","journal-title":"Anesth Analg"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00003246-200204000-00005","article-title":"Time course of platelet counts in critically ill patients.","volume":"30","author":"Akca","year":"2002","journal-title":"Crit Care Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1378\/chest.13-0121","article-title":"Thrombocytopenia in critically ill patients receiving thromboprophylaxis: Frequency, risk factors, and outcomes.","volume":"144","author":"Williamson","year":"2013","journal-title":"Chest"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00003246-200006000-00031","article-title":"Thrombocytopenia and prognosis in intensive care.","volume":"28","author":"Vanderschueren","year":"2000","journal-title":"Crit Care Med"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tmrv.2014.12.001","article-title":"Extracorporeal membrane oxygenation-hemostatic complications.","volume":"29","author":"Murphy","year":"2015","journal-title":"Transfus Med Rev"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1378\/chest.06-2233","article-title":"Platelet count decline: An early prognostic marker in critically ill patients with prolonged ICU stays.","volume":"131","author":"Moreau","year":"2007","journal-title":"Chest"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00134-005-2763-5","article-title":"SAPS 3\u2013From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission.","volume":"31","author":"Moreno","year":"2005","journal-title":"Intensive Care Med"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1097\/00003246-200007000-00067","article-title":"The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates.","volume":"28","author":"Cheung","year":"2000","journal-title":"Crit Care Med"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1213\/ANE.0000000000000554","article-title":"Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.","volume":"120","author":"Tauber","year":"2015","journal-title":"Anesth Analg"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0267659112457969","article-title":"Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation.","volume":"28","author":"Smith","year":"2013","journal-title":"Perfusion"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1749-8090-9-72","article-title":"Effects of continuous renal replacement therapy on intestinal mucosal barrier function during extracorporeal membrane oxygenation in a porcine model.","volume":"9","author":"He","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1378\/chest.115.5.1363","article-title":"Thrombocytopenia in a surgical ICU.","volume":"115","author":"St\u00e9phan","year":"1999","journal-title":"Chest"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1378\/chest.10-2243","article-title":"The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review.","volume":"139","author":"Hui","year":"2011","journal-title":"Chest"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00134-015-4012-x","article-title":"Understanding platelet dysfunction in sepsis.","volume":"42","author":"Pigozzi","year":"2016","journal-title":"Intensive Care Med"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012.","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jtcvs.2012.01.005","article-title":"Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: A case-control study.","volume":"143","author":"Pieri","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PCC.0b013e3181e28894","article-title":"Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults.","volume":"12","author":"Bizzarro","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"e0124034","DOI":"10.1371\/journal.pone.0124034","article-title":"Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support.","volume":"10","author":"Omar","year":"2015","journal-title":"PLoS One"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/CCM.0000000000000128","article-title":"Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: Prevalence, risk factors, and outcomes.","volume":"42","author":"Lou","year":"2014","journal-title":"Crit Care Med"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.blre.2010.09.002","article-title":"DIC: Which laboratory tests are most useful.","volume":"25","author":"Levi","year":"2011","journal-title":"Blood Rev"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/j.1537-2995.2007.01573.x","article-title":"A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery.","volume":"48","author":"Despotis","year":"2008","journal-title":"Transfusion"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/MCC.0000000000000259","article-title":"Heparin-induced thrombocytopenia.","volume":"21","author":"Warkentin","year":"2015","journal-title":"Curr Opin Crit Care"},{"issue":"Suppl 3","key":"R25-20230728","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0030-1250184","article-title":"Heparin-induced thrombocytopenia type II after cardiac surgery: Predictors and outcome.","volume":"58","author":"Assmann","year":"2010","journal-title":"Thorac Cardiovasc Surg"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1378\/chest.11-3074","article-title":"Clinical and biologic features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU.","volume":"142","author":"Trehel-Tursis","year":"2012","journal-title":"Chest"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/aor.12335","article-title":"Do we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits.","volume":"39","author":"Silvetti","year":"2015","journal-title":"Artif Organs"},{"key":"R29-20230728","first-page":"187","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201612000-00040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T06:57:38Z","timestamp":1690527458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201612000-00040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000001964","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}